Aurora Labs AI Stock Analysis
Want to see AU:A3D full AI Analyst Report?
Aurora Labs (A3D) AI Stock Analysis
Aurora Labs
(ASX:A3D)
Low score primarily driven by weak financial performance with ongoing losses and cash burn, compounded by unattractive valuation from negative earnings. Mildly positive technical indicators offer limited offset.
Aurora Labs (A3D) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 30.89M
- Dividend Yield
- ―
- Average Volume (3M)
- 497.57K
- Price to Earnings (P/E)
- -5.3
- Beta (1Y)
- 1.20
- Revenue Growth
- -24.15%
- EPS Growth
- -11.22%
- Country
- Australia
- Employees
- 18
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Machinery
Aurora Labs Business Overview & Revenue Model
Company Description
Established in 2014 and headquartered in Canning Vale, Australia, Aurora Labs Limited specializes in the creation, enhancement, and market introduction of 3D metal printers, along with complementary powders, digital components, and relevant intellect...
How the Company Makes Money
Aurora Labs’ revenue model is based on commercializing its metal additive manufacturing technology. The primary expected revenue streams include: (1) sales of metal 3D printing machines/systems to industrial customers; (2) recurring revenue from asso...
Aurora Labs Financial Statement Overview
Summary
Revenue volatility, persistent net losses, negative gross profit, and consistently negative operating and free cash flows indicate weak profitability and high cash burn, despite some balance sheet stability from low debt.
Income Statement
18Very NegativeBalance Sheet
52NeutralCash Flow
12Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 564.22K | 564.22K | 743.83K | 174.30K | 134.56K | 32.20K |
| Gross Profit | -3.14M | -3.14M | 326.65K | 57.13K | 58.81K | 13.89K |
| EBITDA | -5.66M | -5.66M | -4.40M | -3.23M | -3.37M | -3.70M |
| Net Income | -5.11M | -5.11M | -3.75M | -2.81M | -2.96M | -3.15M |
Balance Sheet | ||||||
| Total Assets | 4.91M | 4.91M | 2.91M | 3.08M | 2.18M | 3.35M |
| Cash, Cash Equivalents and Short-Term Investments | 1.98M | 1.98M | 1.16M | 1.65M | 986.80K | 1.95M |
| Total Debt | 99.74K | 99.74K | 956.01K | 842.94K | 65.39K | 160.53K |
| Total Liabilities | 2.44M | 2.44M | 1.84M | 1.30M | 719.35K | 716.58K |
| Stockholders Equity | 2.47M | 2.47M | 1.07M | 1.78M | 1.46M | 2.63M |
Cash Flow | ||||||
| Free Cash Flow | -4.16M | -4.16M | -2.80M | -2.41M | -2.60M | -2.68M |
| Operating Cash Flow | -3.01M | -3.01M | -2.62M | -2.40M | -2.57M | -2.63M |
| Investing Cash Flow | -1.15M | -1.15M | -180.58K | -7,690 | -23.07K | -48.42K |
| Financing Cash Flow | 5.00M | 5.00M | 2.31M | 3.07M | 1.63M | 3.25M |
Aurora Labs Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:A3D, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bullish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 53.41 is Neutral, neither overbought nor oversold. The STOCH value of 36.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:A3D.
Aurora Labs Peers Comparison
Overall Rating
AU:LBL67Neutral
AU:AL352Neutral- AU:A3D44Neutral
AU:TTT43Neutral
AU:MPW38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:LBL | 67Neutral | AUD 72.58M | 14.70 | 11.27% | 2.64% | 10.80% | 26.91% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| AU:AL3 | 52Neutral | AUD 65.83M | -13.58 | -14.54% | ― | 59.16% | 48.08% |
| AU:A3D | 44Neutral | AUD 30.89M | -5.32 | -149.42% | ― | -24.15% | -11.22% |
| AU:TTT | 43Neutral | AUD 164.89M | -3.80 | -74.68% | ― | -1.41% | -4.04% |
| AU:MPW | 38Underperform | AUD 187.67M | -11.67 | -67.53% | ― | -9.99% | -245.74% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:A3D | Aurora Labs Ltd. | 0.06 | 0.01 | 14.29% | |
| AU:TTT | Titomic Ltd | 0.09 | -0.14 | -60.00% | |
| AU:AL3 | AML3D Ltd | 0.11 | -0.06 | -35.29% | |
| AU:MPW | Metal Powder Works Limited | 1.25 | -0.88 | -41.31% | |
| AU:LBL | Laserbond Limited | 0.60 | 0.12 | 24.74% |
Aurora Labs Corporate Events
Aurora Labs Updates Securities Placement Settlement
Aurora Labs Limited has updated its proposed securities issue arrangements. Part of the settlement originally allocated to the T1 placement has been moved to the T2 placement, revising the timing and structure of the transaction without disclosing ch...
Aurora Labs Applies to Quote 81.99 Million Shares
Aurora Labs Limited, listed on the ASX under code A3D, applied to quote 81,990,081 fully paid ordinary shares on November 6, 2026. The securities were issued as part of a transaction previously announced to the market, increasing the company’s quoted...
Aurora Labs Secures First UK Defence Engine Sale
Aurora Labs is an industrial technology company specializing in 3D metal-printed parts, metal printers and related intellectual property, while developing propulsion systems for unmanned aerial systems in the defence market. Its international focus i...
Aurora Labs Secures AS9100D Certification and First U.S. Engine Order as Production Scale-Up Accelerates
Aurora Labs reported continued progress in shifting from technology development to production scale-up and commercial execution during the September quarter of 2026. The company advanced detailed manufacturing capacity planning, including facility la...
Aurora Labs Plans Major ASX Share and Option Issue to Bolster Capital
Aurora Labs Limited has announced a proposed issue of securities on the ASX, including up to 83,000,005 ordinary fully paid shares under its A3D ticker. The issuance structure is designed to leverage public market access and equity financing as part...
Aurora Labs Raises $6m to Scale Defence Propulsion Manufacturing
Aurora Labs Limited is an Australian advanced manufacturing company focused on metal additive manufacturing and proprietary turbojet propulsion systems for defence and aerospace customers. Operating from a vertically integrated, AS9100D-certified fac...
Aurora Labs Halts ASX Trading Ahead of Material Private Placement Announcement
Aurora Labs Limited has requested and received a trading halt on its ASX-listed securities, with the halt in place until either the release of a forthcoming announcement or the market’s reopening on Wednesday, 28 October 2026. The halt was initiated...
Aurora Labs lands first U.S. turbojet engine sale
Aurora Labs has secured its first U.S. order for three AU4 turbojet engines and integration services from a U.S.-based aerospace and defence-focused start-up, in a package valued at US$42,000. The engines will support an experimental aircraft program...
Aurora Labs Issues 7.5 Million Unlisted Options in Capital Structure Move
Aurora Labs Limited has issued 7.5 million unlisted options, exercisable at $0.12 and expiring on October 20, 2029, as part of a previously announced transaction. The new options, which will not be quoted on the ASX, expand the company’s pool of unqu...
Aurora Labs Sets Terms for 7.5 Million Consultant Options
Aurora Labs has detailed the terms for 7.5 million options to be issued, each convertible into one ordinary share at an exercise price of $0.12 and expiring three years from issuance. The options vest in tranches, with an initial 1.25 million vesting...
Aurora Labs Plans Issue of 7.5 Million Unlisted Options
Aurora Labs Limited has announced a proposed issue of 7.5 million unlisted options, each exercisable at $0.12 and expiring on 20 October 2029, as part of a placement or other type of securities issue. The move signals the company’s continued use of e...
Aurora Labs Sets November AGM to Vote on Directors and Remuneration Report
Aurora Labs Ltd has called its Annual General Meeting for 13 November 2026 in Perth, urging shareholders to lodge proxy votes ahead of the session to ensure their participation in key governance decisions. Eligibility to vote is set by the share regi...
Aurora Labs Reshapes Leadership to Drive Defence Manufacturing Push
Aurora Labs has overhauled its executive leadership, appointing strategy chief Andrew Garth as chief executive officer and moving former CEO Rebekah Letheby into the newly defined role of chief operating officer. The company says the changes are inte...
Aurora Labs Files Updated Corporate Governance Statement with ASX
Aurora Labs has lodged its latest corporate governance statement and accompanying Appendix 4G with the ASX for the financial year ended 30 June 2026. The company has opted to host its corporate governance statement on its website, confirming it is ac...
Aurora Labs Details ASX-Aligned Governance Amid Diversity Focus
Aurora Labs Limited operates in the advanced manufacturing and technology sector, focusing on 3D printing solutions and related systems, with its corporate compliance materials hosted on auroralabs3d.com. The company is listed on the ASX and position...
Aurora Labs Corrects Director Option Expiry in Updated ASX Notice
Aurora Labs has corrected a previously lodged director’s interest notice relating to options held by Chief Executive Officer and director Rebekah Letheby, clarifying that her 3,000,000 options are exercisable at $0.14 each on or before 15 December 20...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 25, 2026